Navigation Links
Therapy Changes Releases New Guide on Group Therapy
Date:9/2/2014

San Diego, CA (PRWEB) September 02, 2014

Today, Therapy Changes released a new guide titled, “Is Group Therapy Right for Me?” The guide outlines common questions an individual may have to joining group therapy or counseling, in addition to common types of groups an individual can attend.

“People in group therapy improve not only from the interventions of the therapist, but also from observing others in the group and receiving feedback from group members,” says Rochelle Perper, Ph.D. and founder of Therapy Changes.

Some of the common questions answered in the guide includes:

  • How to determine the best group therapy
  • Who is involved in group therapy
  • What to expect from a group therapy session
  • What to if a group therapy isn’t right for the patient

The guide also shares overall benefits to group therapy and three types of sessions offered by Therapy Changes. To download the free guide, visit the Therapy Changes website.

Read the full story at http://www.prweb.com/releases/therapychanges/cognitivetherapy/prweb12139181.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Page: 1

Related medicine news :

1. Hands On HealthCare Massage Therapy and Wellness Day Spa Announces Fundraising and Raising Awareness of Childhood Cancer
2. Leader in Manual Therapy Continuing Education Makes it Easier for Physical Therapists to Improve Results on Patients
3. Healthpointe is Now Offering Clinical Rotations for Chapman University Physical Therapy Students
4. Mice study shows efficacy of new gene therapy approach for toxin exposures
5. ESC launches journal on CV pharmacotherapy
6. Research demonstrates potential method to better control lung cancer using radiotherapy
7. Light Therapy a Good Option for Pre-Cancerous Skin Lesions, Study Says
8. Photodynamic therapy vs. cryotherapy for actinic keratoses
9. Atlantic NeuroSurgical Specialists (ANS) Announces Availability of New Therapy for Brain Cancer
10. Promising new cancer therapy uses molecular Trash Man to exploit a common cancer defense
11. PartnerTech Inc. and Impact Cryotherapy Announce Made in America Manufacturing Initiative
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2017)... ... February 26, 2017 , ... ... technology standard in staffing, scheduling, and reporting for healthcare organizations. This comprehensive ... throughout the entire staffing process. StaffBridge technology improves staffing efficiency, maximizes resource ...
(Date:2/24/2017)... MN (PRWEB) , ... February 24, 2017 , ... ... of its newly designed TaskMate Go. Core benefits and advantages built into the ... and a stylish, functional look and feel. Ability to gain the benefits embedded ...
(Date:2/24/2017)... ... February 24, 2017 , ... Dr. Ronald ... officially announced the appointment of Peter A. Bell, DO, MBA, HPF, FACOEP-dist., FACEP, ... (LUCOM), beginning April 10. Dr. Bell comes to Liberty from the Ohio University ...
(Date:2/24/2017)... ... February 24, 2017 , ... The narrative in “ Signal 8: ... ’s true account of his paramedic experiences. Schanssema describes the tragedies he saw, as ... attempts to overcome them. , Schanssema, initially unsure of the career path he wanted ...
(Date:2/24/2017)... ... February 24, 2017 , ... Indiana Fiber Network (IFN) President ... later this year. Dyer started as the Chairman of the Management Committee when ... of the corporation including the recruitment of investor/owners and development of the business plan. ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... ITL Limited, ( ASX : ITD ), une société de ... excellents résultats semestriels clos le 31 décembre 2016 par ... « Résultats et mise à jour sur la croissance biomédicale ... Faits marquants Bénéfice ... hausse de 104 %) Bénéfice par action ...
(Date:2/24/2017)... 23, 2017 Non-alcoholic steatohepataitis (NASH) ... various drugs being developed for the treatment ... drugs that are in various phases of ... focuses on novel pharmacologic drugs & regenerative ... therapies, recombinant proteins and RNA-based therapeutics, but ...
(Date:2/24/2017)... Feb. 24, 2017  Xynomic Pharmaceuticals, Inc., an oncology ... it has acquired exclusive worldwide rights to develop, ... HDAC inhibitor targeting hematological and solid tumors. ... 1 and 2 clinical trials of Abexinostat in ... have already been completed, demonstrating that Abexinostat is ...
Breaking Medicine Technology: